On Friday, Sangamo Therapeutics Inc (NASDAQ: SGMO) opened higher 9.97% from the last session, before settling in for the closing price of $0.38. Price fluctuations for SGMO have ranged from $0.38 to $2.84 over the past 52 weeks.
A company in the Healthcare sector has jumped its sales by 10.57% annually for the last half of the decade. Company’s average yearly earnings per share was noted 31.67% at the time writing. With a float of $328.57 million, this company’s outstanding shares have now reached $336.49 million.
Sangamo Therapeutics Inc (SGMO) Insider and Institutional Ownership
A key investor’s attitude towards the stock of the Biotechnology industry is another important factor to consider. The insider ownership of Sangamo Therapeutics Inc is 2.36%, while institutional ownership is 18.71%.
Sangamo Therapeutics Inc (SGMO) Latest Financial update
If we go through the results of last quarter, which was made public on 12/31/2024, the company posted -0.11 earnings per share (EPS) for the quarter, coming under the agreed prediction (set at -0.05) by -0.06. Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.04 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around 31.67% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will surge by 73.79% during the next five years compared to 10.57% growth over the previous five years of trading.
Sangamo Therapeutics Inc (NASDAQ: SGMO) Trading Performance Indicators
Check out the current performance indicators for Sangamo Therapeutics Inc (SGMO). In the past quarter, the stock posted a quick ratio of 0.88. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 4.33.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -0.44, a number that is poised to hit -0.01 in the next quarter and is forecasted to reach -0.32 in one year’s time.
Technical Analysis of Sangamo Therapeutics Inc (SGMO)
Let’s dig in a bit further. During the last 5-days, its volume was 17.07 million. That was better than the volume of 6.02 million it reported in year-ago period. As of the previous 9 days, the stock’s Stochastic %D was 8.13%.
During the past 100 days, Sangamo Therapeutics Inc’s (SGMO) raw stochastic average was set at 10.17%, which indicates a significant decrease from 18.21% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 0.0513 in the past 14 days, which was higher than the 0.0465 volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $0.5821, while its 200-day Moving Average is $0.6432. However, in the short run, Sangamo Therapeutics Inc’s stock first resistance to watch stands at $0.5190. Second resistance stands at $0.6147. The third major resistance level sits at $0.6734. If the price goes on to break the first support level at $0.3646, it is likely to go to the next support level at $0.3059. The third support level lies at $0.2102 if the price breaches the second support level.
Sangamo Therapeutics Inc (NASDAQ: SGMO) Key Stats
There are currently 336,495K shares outstanding in the company with a market cap of 142.47 million. Presently, the company’s annual sales total 57,800 K according to its annual income of -97,940 K. Last quarter, the company’s sales amounted to 580 K and its income totaled -34,930 K.
